Insider Transactions in Q4 2025 at Madrigal Pharmaceuticals, Inc. (MDGL)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 13
2025
|
Richard S Levy Director |
SELL
Open market or private sale
|
Direct |
8,500
-2.36%
|
$4,437,000
$522.33 P/Share
|
|
Nov 13
2025
|
Richard S Levy Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,500
+13.18%
|
$93,500
$11.91 P/Share
|
|
Nov 05
2025
|
Kenneth Bate Director |
SELL
Open market or private sale
|
Direct |
16,575
-15.93%
|
$8,038,875
$485.61 P/Share
|
|
Nov 05
2025
|
Kenneth Bate Director |
BUY
Exercise of conversion of derivative security
|
Direct |
16,575
+27.12%
|
$3,265,275
$197.76 P/Share
|